首页> 中文期刊>中国药理学通报 >不同分子量美沙拉嗪PEG修饰物的大鼠在体肠吸收研究

不同分子量美沙拉嗪PEG修饰物的大鼠在体肠吸收研究

     

摘要

Aim To study the absorption kinetics of se-ries molecular weight 5-ASA-mPEG in rats intestine. Methods The in situ intestinal absorption property of 5-ASA-mPEG in rats was investigated by means of sin-gle-pass perfusion, and HPLC method was established to determine the drug concentration in the perfusate. Results The drug concentration and the site of intes-tine segments had little effect on the drug absorption constant ( Ka ) and apparent absorption coefficient (Papp). The perfusion flow rate and the variable mo-lecular weight of 5-ASA-mPEG could significantly af-fect the Ka and Papp. Conclusion 5-ASA-mPEG can be absorbed at all segments of the intestine of rats and has no specific absorption site. It is preliminarily in-ferred that the absorption mechanism of 5-ASA-mPEG is passive transportation. The intestinal absorption of 5-ASA-mPEG shows a downward trend with the increase in molecular weight. The results shows that the modifi-cation of 5-ASA by PEG can effectively inhibit the in-testinal absorption of mesalazine.%目的:对系列分子量的美沙拉嗪PEG修饰物(5-ASA-mPEG)的大鼠肠道吸收动力学特征进行考察。方法采用单向灌流技术考察5-ASA-mPEG的大鼠在体肠吸收性质,以高效液相色谱法测定灌流液中药物的浓度。结果考察范围内药物浓度及药物吸收部位对药物吸收速率常数( Ka )和表观吸收系数( Papp )无显著性影响。灌流速度及5-ASA-mPEG分子量在考察范围内对Ka 及Papp具有明显影响。结论5-ASA-mPEG修饰物在全肠道均有吸收,无明显吸收特定部位,初步判定其吸收机制为被动扩散;随5-ASA-mPEG分子量提高,其肠道吸收呈下降趋势,表明PEG修饰能够抑制5-ASA的肠道吸收过程。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号